Lixte Biotechnology Warrants
LIXTW
LIXTW was delisted on the 26th of November, 2025.
4 hedge funds and large institutions have $1.45K invested in Lixte Biotechnology Warrants in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
1.2% more ownership
Funds ownership: 2.17% → 3.37% (+1.2%)
12% less capital invested
Capital invested by funds: $1.65K → $1.45K (-$203)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$82 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$26 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $722 | -$26 | -801 | -3% |
|
|
CS
2
Clear Street
New York
| $648 | – | – | – |
|
|
NFSG
3
Newbridge Financial Services Group
Boca Raton,
Florida
| $72 | +$82 | +2,500 | New |
|
4
Bank of America
Charlotte,
North Carolina
| $3 | – | – | – |
|
LIXTW Hedge Fund Activity: Q2 2025 in Review
4 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Lixte Biotechnology Warrants (LIXTW) for Q2 2025, worth a combined $1.45K — down 12% from $1.65K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new LIXTW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Newbridge Financial Services Group, opening a new position worth an estimated $82. The largest seller was Citadel Advisors, cutting an estimated $26.
- 4 institutional investors held Lixte Biotechnology Warrants (LIXTW) as of Q2 2025, up from 3 in Q1 2025.
- Funds reported $1.45K of Lixte Biotechnology Warrants stock for Q2 2025, down 12% quarter-over-quarter.
- 1 fund opened new Lixte Biotechnology Warrants positions in Q2 2025 and 0 closed out, a net change of +1 holder.
- The largest Lixte Biotechnology Warrants buyer in Q2 2025 was Newbridge Financial Services Group, an estimated $82 added.
- The largest Lixte Biotechnology Warrants seller in Q2 2025 was Citadel Advisors, an estimated $26 sold.
Based on aggregated 13F filings for Q2 2025.